Docetaxel, nedaplatin, fluorouracil

DRUG2 trials

Sponsors

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Conditions

Nasopharyngeal Carcinoma

Phase 2

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

CompletedNCT04834206

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNasopharyngeal Carcinoma

Start: 2021-05-01End: 2022-05-01Updated: 2022-05-10

Phase 3

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

RecruitingNCT04437329

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNasopharyngeal Carcinoma

Start: 2020-08-01End: 2029-06-30Target: 352Updated: 2022-05-10

Related Papers

Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trial.

2026-01-06

Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trial.

Journal of Clinical Oncology2023-06-01